MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 12 - per page Next page
Order by
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Two novel classes of compounds useful as radioligands for in vivo imaging of beta-amyloid peptides and plaques in humans More
Contrast agents for ultrasonic imaging, destruction of clots, ultrasound-induced permeability of blood vessels and other tissues, targeted drug delivery, or to enhance ultrasonic tissue ablation. More
This invention concerns a position and orientation sensor designed for use with existing ultrasound instrumentation to permit the real-time measurement of blood volume flow rate within a vessel. More
A new excitation pulse sequence for the acquisition of Magnetic Resonance Imaging (MRI) data of particular usefulness in Magnetic Resonance Angiography (MRA). More
This device allows for safe in situ exploration of myofascial pain biochemistry with minimal system perturbation. More
Immortalized cell lines that constitutively express different fluorescent proteins, in vitro angiogenesis assays, and a software application have been developed. More
Methods, systems and transgenic animals useful for screening, diagnosing and treating FUS1 related disorders More
Using this technology, it will be possible to create high quality images for viewing the colon surface in 3D with reduced false positives in the medium-sized range for colon polyps. More
Displaying 1..10 of 12 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Need competitive intelligence information
Stem Cell USA
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us